Optimal Management of Women With Wrist Fractures

NCT00226031 | Completed

• 1 other identifier: KTS-62358
• Study Type: interventional
• Target: 270
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the effectiveness of a multifaceted intervention (reminder and educational material) in improving the evaluation of osteoporosis follow-up care of post-menopausal women with wrist fractures by their primary care physicians. The intervention is directed at improving the gap in continuity of care between emergency/fracture clinics and family physicians, and reducing knowledge gaps.

Conditions

Osteoporosis; Osteopenia

Keywords

Osteoporosis; Wrist fractures; Knowledge translation; Implementation; Educational reminder

Outcome Measures

Primary Outcomes (1)

• Proportion of women who are prescribed anti-osteoporosis therapy within 6 months of sustaining a forearm fracture.

  6 months

Secondary Outcomes (2)

• Proportion of women in whom a bone density scan is ordered and the proportion of women who receive counseling advice about osteoporosis from their family physicians.

  6 months

• Women's knowledge about osteoporosis and fractures (Osteoporosis Knowledge Questionnaire).

  6 months

Study Arms (2)

1

ACTIVE COMPARATOR

Usual care.

Procedure: Educational Material and Reminder

2

EXPERIMENTAL

Mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the family physician and a letter and educational package for the women.

Procedure: Educational Material and Reminder

Interventions

Educational Material and Reminder PROCEDURE

Family practices were randomly assigned to intervention or usual care. The intervention was a mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the GP and a letter and educational package for the women.

1; 2

Eligibility Criteria

• Age: 50 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Postmenopausal women with low trauma distal radius fracture (confirmed by x-ray).
• Can be taking Didrocal (etidronate), Miacalcin (calcitonin),or hormone replacement therapy .

You may not qualify if:

• Women with fractures of the elbow, mid radius, scaphoid, or injury to wrists (without actual fracture).
• Significant cognitive impairment (which would preclude them from filling out simple questionnaires).
• Women already taking osteoporosis therapy, ie. either Fosamax (alendronate), Actonel (risedronate), or the selective estrogen receptor modulator, Evista (raloxifene).

Sponsors & Collaborators

• Queen's University: lead
• Canadian Institutes of Health Research (CIHR): collaborator

Study Sites (1)

Queen's University

Kingston, Ontario, K7L 3N6, Canada

Location

MeSH Terms

Conditions

Osteoporosis; Bone Diseases, Metabolic; Wrist Fractures

Condition Hierarchy (Ancestors)

Bone Diseases; Musculoskeletal Diseases; Metabolic Diseases; Nutritional and Metabolic Diseases; Wrist Injuries; Arm Injuries; Wounds and Injuries; Fractures, Bone

Study Officials

• Ann B Cranney, MD

  Queen's University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 22, 2005
• First Posted: September 26, 2005
• Study Start: September 1, 2003
• Primary Completion: August 1, 2006
• Study Completion: August 1, 2007
• Last Updated: March 11, 2015

Record last verified: 2015-03

Locations

CA (1)